Propolis for Management of Chemotherapy-Induced Oral Mucositis in Pediatric Patients

Phase 2Not Yet RecruitingNCT07073092

Ain Shams University50 enrolled

Overview

The goal of this clinical trial is to evaluate the efficacy of propolis in the prevention of oral mucositis and reducing pain score in children undergoing chemotherapy, and assessing its impact on body mass index, pediatric quality of life and total antioxidant assay. The main question it aims to answer is: What is the effect of propolis on oral mucositis scores in children undergoing chemotherapy? Participants will: Take propolis 3 times daily for 21 days follow up weekly for 3 weeks

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

Conditions

Oral Mucositis Due to Chemotherapy

Interventions

propolisDRUG

propolis medicated jelly candy.

chlorohexidine mouthwash and topical antifungalDRUG

chlorohexidine mouthwash and topical antifungal

Eligibility

Sex: ALLMin age: 2 YearsMax age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Children of both genders less than 18 years receiving intensive chemotherapy. * Oncology patients receiving intensified chemotherapy at Oncology unit, Children's Hospital, Ain Shams University, Egypt, who meet the following criteria: * Taking intensified chemotherapy * A healthy oral mucosa. Exclusion Criteria: * Allergy to bee products. * Severe systemic illness unrelated to cancer (Diabetes, Hypertension, …) * Inability to take oral medication or unwillingness to participate in the study * Radiotherapy in the head and neck area. * Malignant or potentially malignant lesions of the oral cavity. * Undergoing any other procedures to prevent oral mucositis except standard oral care. * Patients are unable to commit to the study.

Locations (1)

faculty of dentistry Ain shams university

Cairo, Egypt

Outcomes

Primary Outcomes

oral mucositis score (WHO)

Assess the effectiveness of propolis in treatment of chemotherapy induced oral mucositis in pediatric cancer patients using the WHO Scale (WHO), scoring from 0 to 4.

Time frame: 3 weeks

Secondary Outcomes

pain (VAS)

Assess the effectiveness of propolis on pain levels. Pain will be assessed by (visual analogue scale). The P-VAS evaluation ranges from 0 to 10, where 0 indicates "no pain" and 10 indicates "the most severe pain"

Time frame: 3 weeks

body mass index

Assess the effectiveness of propolis on BMI in pediatric patients undergoing chemotherapy. Body mass index (BMI, kg/m2) was defined as the body mass (kg) divided by the square of the body height (m).

Time frame: 3 weeks

Pediatric Quality of Life

Assess the effectiveness of propolis on Pediatric Quality of Life using the Arabic validated version of Peds QL™ Inventory both Child Self Report and Parent Proxy Report. 0 = Never, 1 = Almost Never, 2 = Sometimes, 3 = Often, 4 = Almost Always Scoring Method: 1\. Reverse Scoring System: 0 = 100 points, 1 = 75 points, 2 = 50 points, 3 = 25 points, 4 = 0 points 2. Domain Score Calculation: Sum all question scores within a domain and divide by the number of questions in that domain. 3\. Total PedsQL Score Calculation: Sum all domain scores and divide by the total number of questions. Higher scores indicate better quality of life.

Time frame: 3 weeks

Total anti-oxidant assay

Assess the effectiveness of propolis on total antioxidant assay in pediatric patients undergoing chemotherapy using biochemical analysis

Time frame: 3 weeks

Central Contacts

Dina B. Elkhouly

CONTACT

+201063147477 dinaborham@dent.asu.edu.eg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.